Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
The first and only approved dual inhibitor of IL-17A and IL-17F1-6
February 2026
BIMZELX® Demonstrated Deep and Sustained Efficacy to 3 Years Across Multiple Disease Domains of PsA and the Full axSpA Spectrum…
Read more
15 Aug 2025
Study Explores Real-World Rituximab Use in Rheumatoid Arthritis
In a long-term real-world study, researchers found that flare-based rituximab retreatment for rheumatoid arthritis maintained high drug retention but led to cycles of fluctuating disease activity and wellbeing.
14 Aug 2025
Breaking Free from Glucocorticoids in PMR
In this symposium, Anisha Bharadwaj Dua explored the prevalence and impact of comorbidities in patients with…
13 Aug 2025
How to Tackle Exercise Barriers in Inflammatory Myopathies?
People with idiopathic inflammatory myopathies (IIM) face unique physical and emotional challenges when it comes to exercise.
9 Aug 2025
People With Rheumatoid Arthritis Face Higher Risk of Blood Clots
A UK population-based study found that people with rheumatoid arthritis have a significantly increased risk of venous thromboembolism, including younger patients and those with a normal BMI. The findings highlight the need to assess blood clot risk in all RA patients, regardless of traditional VTE risk factors.
9 Aug 2025
Patient Education Tied to Quality of Life in Rheumatoid Arthritis
A new study of RA patients in Jordan reveals that disease knowledge is higher among younger, more educated individuals, though income and disease activity have a greater influence on quality of life.
7 Aug 2025
Biologic Use During Pregnancy Differs by Autoimmune Condition
Biologic therapy is commonly continued during pregnancy among women with autoimmune diseases, but usage varies greatly by condition, new research shows.
5 Aug 2025
Current trends of methotrexate therapy
Explore the evolving role of methotrexate (MTX) in rheumatoid arthritis (RA) care in this expert-led podcast featuring leading…
1 Aug 2025
Home-Based Brain Stimulation Reduces Pain and Disability in Fibromyalgia
A randomised trial finds that home-based brain stimulation plus exercise and education reduces pain-related disability in fibromyalgia patients, even among placebo responders.
Loading posts...
« Previous
1
…
7
8
9
10
11
…
83
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View